Texas

Cellenkos, Inc. Announces Neuroinflammation Research Collaboration with The University of Texas Health Science Center at Houston

HOUSTON, June 22, 2018 /PRNewswire/ -- Cellenkos™ and The University Of Texas Health Science Center at Houston today announce a research collaboration for application of cord blood-derived regulatory T cells (CK0801) as…
Continue Reading »
Texas

CenterPoint Energy to Pay Additional Interest on its 2.0 percent Zero-Premium Exchangeable Subordinated Notes due 2029

HOUSTON, June 22, 2018 /PRNewswire/ -- CenterPoint Energy, Inc. (NYSE: CNP) has established July 2, 2018, as an Additional Interest Regular Record Date under the terms of its percent Zero-Premium…
Continue Reading »